Literature DB >> 21631711

Acute aldicarb toxicity in dogs: 15 cases (2001-2009).

John D Anastasio1, Claire R Sharp.   

Abstract

OBJECTIVE: To describe the common clinical signs, laboratory abnormalities, treatment, and prognosis associated with acute aldicarb toxicosis in dogs.
DESIGN: Retrospective observational study from 2001 to 2009.
SETTING: Urban referral hospital. ANIMALS: Fifteen client-owned dogs.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The most common clinical signs associated with acute aldicarb toxicosis were vomiting, ptyalism, diarrhea, and tremors. Of the 15 dogs, 11 were admitted to the hospital for treatment, 2 were euthanized at presentation and 2 were discharged against medical advice following minimal treatment and lost to follow-up. Laboratory abnormalities included lactic acidosis and hyperglycemia in 12 and 9 patients, respectively. Treatment of hospitalized dogs included induction of emesis with apomorphine (4 dogs), activated charcoal (5), IV fluids (11), atropine (7), methocarbamol (3), diazepam (1), pralidoxime (1) and diphenhydramine (1). Ten of 11 hospitalized dogs survived to discharge; 1 was euthanized following a respiratory arrest after 36 hours of hospitalization. One patient received mechanical ventilation and treatment for pneumonia before discharge from the hospital. The median duration of hospitalization was 22 hours (range 12-168 h).
CONCLUSIONS: Acute aldicarb toxicosis carries a good prognosis for survival and hospital discharge with treatment. Supportive care should be considered for at least 18-24 hours to monitor for response to therapy and development of respiratory failure. © Veterinary Emergency and Critical Care Society 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631711     DOI: 10.1111/j.1476-4431.2011.00613.x

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  2 in total

1.  Death by chumbinho: aldicarb intoxication-regarding a corpse in decomposition.

Authors:  Carlos Durão; Marcos P Machado
Journal:  Int J Legal Med       Date:  2016-02-25       Impact factor: 2.686

2.  Organoleptic assessment and median lethal dose determination of oral aldicarb in rats.

Authors:  Nathaniel C Rice; Noah A Rauscher; Mark C Moffett; Todd M Myers
Journal:  Ann N Y Acad Sci       Date:  2020-08-05       Impact factor: 6.499

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.